BHC Bausch Health Companies Inc.

$6.76 -0.88%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Bausch Health Companies Inc. (BHC) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $2.5 billion. Shares last traded at $6.76, 15.5% below their 52-week high. Over the past year the stock is down 8.2%. Net profit margin is -10.1%, below the peer median of -8.9%. Revenue grew 6.7% year over year. The shares yield 11.1% in dividends.

Market Cap

$2.5B

Shares Out

374.0M

EPS (TTM)

$-5.98

P/E Ratio

—

P/S Ratio

0.23

P/B Ratio

—

Dividend / Share

$0.75

Dividend Yield

11.09%

52-Week High

$8.00

52-Week Low

$4.33

Volume

144,231

Avg Vol (3m)

194,407.857

Performance

+7.30%

+7.47%

+29.01%

+21.36%

YTD

-6.37%

-8.15%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

60.46

SMA (50)

$5.67

SMA (200)

$5.85

Price vs SMA50

+19.25%

Price vs SMA200

+15.49%

ATR (14)

$0.37

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$10.9B

Net Income

$-1098M

Gross Margin

—

Operating Margin

8.1%

Net Margin

-10.1%

Return on Equity

62.0%

Return on Assets

-4.4%

Current Ratio

1.44

Debt / Equity

-11.71

Revenue Growth (YoY)

+6.7%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-3.12	2026-07-30
Q1 2026	$-3.82	2026-04-30
FY 2025	$0.42	2026-02-19
Q3 2025	$0.72	2025-10-30
Q2 2026	$0.24	2026-07-30
Q1 2026	$-0.16	2026-04-30

Full earnings history →

Pharmaceutical Preparations peers

BHC vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

0.23 / 11.11 med

-98% discount

Net margin vs peers

-10.1% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.